Latex Agglutination Test Kits Market Size Report, 2024-2032
Latex Agglutination Test Kits Market Size Report, 2024-2032

Latex Agglutination Test Kits Market Share, Size, Trends, Industry Analysis Report, By Test Type (Antibody Detection, Antigen Testing, and Others); By Sample Type; By End User; By Region; Segment Forecast, 2024 – 2032

  • Published Date:Mar-2024
  • Pages: 116
  • Format: PDF
  • Report ID: PM4446
  • Base Year: 2023
  • Historical Data: 2019-2022

Report Outlook

The global latex agglutination test kits market was valued at USD 634.43 million in 2023 and is expected to grow at a CAGR of 5.5% during the forecast period.

The widespread use of latex agglutination kits for the detection of antigens and antibodies in body fluids such as cerebrospinal fluid, urine, saliva, and blood, are further likely to influence market’s growth. For instance, according to our findings, there are more than 10 million people affected from autoimmune diseases in the United States, that accounts for almost 3% of country’s population.

In addition, rising focus of key market companies on research & development activities and implementation on evaluation of sensitivity and efficacy of product that led to creation of new test kits with enhanced capabilities and features, are further anticipated to boost market’s growth.

Latex Agglutination Test Kits Market Size

To Understand More About this Research:Request a Free Sample Report

  • For instance, in July 2023, Roche Diagnostics, introduced Elecsys HCV Duo, 1st automated immunoassay allowing simultaneous determination of the hepatitis C virus antigen & antibody. It can be used to detect the early stage of infection even when the patient is recovering from the virus.

Furthermore, the rapid adoption of point of care techniques or rapid diagnostics for different autoimmune and infectious diseases coupled with the continuous increase in the prevalence for latex agglutination test kits worldwide because they are highly cost-effective and efficient and easily available or accessible across both developed and developing economies, are also anticipated to create lucrative growth opportunities for the market.

  • For instance, according to the World Health Organization, there are 300-500 million cases of malaria globally and around 333 million cases of sexually transmitted diseases, and approx. 14 million people are infected with tuberculosis worldwide.

However, there are several challenges associated with such type of test kits like limited sensitivity and specificity, cross reactivity, and limited multiplexing capability, which are likely to hamper market’s growth.

Latex Agglutination Test Kits Market Size

Industry Dynamics

Growth Drivers

  • Growing use and application areas of test kits and rising R&D activities are key factors expected to boost market growth

The demand for latex agglutination test kits have grown drastically as they are widely used for hepatitis, meningitis, tonsillitis, arthritis, and several other streptococcal infections, whcih has been pushing the market growth forward over the years. In addition, there are numerous ongoing developments in these test kits like addition of multiplex PCR technology that led to the enhancements in their range of applications and performance and allowing for the detection of more than one pathogen in single sample, that could open new growth avenues for the market.

  • For instance, in November 2022, LumiraDX Healthcare, introduced sensitive C-Reactive Protein PoC antigen test. It is also used in various clinical settings to reduce un-necessary antibiotic prescribing which leads to the antimicrobial resistance.

Report Segmentation

The market is primarily segmented based on test type, sample type, end user, and region.

By Test Type

By Sample Type

By End User

By Region

  • Antibody Detection
  • Antigen Testing
  • Others
  • Blood
  • Urine
  • Cerebrospinal
  • Others
  • Hospitals-based Laboratories
  • Standalone Clinical Laboratories
  • Others
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report:Speak to Analyst

By Test Type Analysis

  • Antigen testing segment accounted for the largest market share in 2023

The antigen testing segment accounted for the largest market share. This dominance is attributed to significant increase in the number of people being infected by several types of bacterial, viral, and fungal diseases across the globe.  Also, the rising awareness among healthcare professionals and even in public regarding the importance of early diagnosis and proper treatment, fueling the adoption of antigen testing.

The antibody detection segment is expected to exhibit highest growth. This growth is due to rising adoption rate of antibody detection test because of its various advantageous characteristics including diagnostic accuracy, ease of use, cost-effectiveness, and many others.

By Sample Type Analysis

  • Blood segment held the significant market share in 2023

The blood segment held the majority market share. Segment’s dominance is attributable to higher prevalence and utilization of blood as sample for various diseases detection and substantial increase in the number of blood transfusions being performed worldwide that requires blood as sample.

The urine segment also projected to hold significant market share, on account of their surging use as a sample type for diagnosing disease or to screen the health problems coupled with the rising focus of people for having urinalysis to determine or detect the early signs of various diseases including chronic kidney diseases.

By End User Analysis

  • Standalone clinical laboratories segment is expected to witness highest growth

Clinical laboratories segment will grow at the rapid pace. Segment’s growth is driven by rise in the number of standalone laboratories with access to facilities for conducting infectious disease diagnostics including latex agglutination tests. Beside this, growing collaboration and other strategic activities of these laboratories with diagnostic kit manufacturers that lead to greater adoption of customized test kits, could further boost segment market growth over the coming years.

The hospital-based laboratories segment led the market. This growth is attributed to their larger patient population, access to advanced and innovated healthcare settings, and favorable health reimbursement policies particularly for early diagnosis of infectious diseases.

Latex Agglutination Test Kits Market Size

Regional Insights

  • North America region dominated the global market in 2023

North America region dominated the global market. Region’s dominance is accelerated by rising prevalence of various infectious diseases, presence of well-established and developed healthcare infrastructure, and constant increase in the number of Clinical Laboratory Improvement Amendments-certified laboratories.

  • For instance, according to a recent report by CDC, the visits to the physician offices for the infectious diseases was estimated around 10.2 Mn in the U.S. & the emergency department visits with infectious diseases stood at 3.8 Mn.

Additionally, growing advances in research & development activities that results in the creation of new and more improved test kits and higher proliferation for regulatory approvals and adherence to healthcare industry quality standards, are further likely to create huge demand for these test kits.

Asia Pacific will grow rapidly, owing to robust presence of favorable government healthcare policies and continuous expansion of healthcare infrastructure with governments are heavily investing in R&D activities. Additionally, the region is home to various infectious diseases that led to increased demand for effective diagnostic tools including latex agglutination test kits for the early diagnosis and treatment of diseases. For instance, according to a report by the Economic Times, more than 3 million children and adolescents die from infectious diseases, that is equivalent to one death every 10 second in India.

Latex Agglutination Test Kits Market Size

Key Market Players & Competitive Insights

The latex agglutination test kits market is highly competitive in nature due to presence of numerous rivals in the global space. There are number of companies in the market who are extensively focusing on business expansion and development strategies that includes mergers and acquisitions, collaborations, partnerships, and new product launches. Also, companies are competing on various factors including new product innovation, improving accuracy and sensitivity, incorporating automation, and reducing time to results, which will help them gain a competitive edge in the market.

  • For instance, in January 2023, Gold Standard Diagnostics, announced the acquisition of Microgen Bioproducts, which will further enhance the company’s Food Safety solutions portfolio with biochemical identification and agglutination products.

Some of the major players operating in the global market include:

  • Arlington Scientific Inc.
  • Atlas Medical GmbH
  • Bio-Rad Laboratories Inc.
  • Biotec
  • Calbiotech
  • Creative Diagnostics
  • Eurofins Technologies
  • Hardly Diagnostics
  • HiMedia Laboratories
  • Liofilchem S.r.l.
  • Mast Group Ltd.
  • Ngaio Diagnostics
  • Pro Lab Diagnostics Inc.
  • Thermo Fisher Scientific

Recent Developments

  • In October 2022, Roche, announced about the launch of its new 2.0 antigen test for COVID, with 3 new configurations for testing at the home. It will allow individuals and healthcare systems to easily access to the reliable rapid testing.
  • In July 2022, Bio-Rad Laboratories, introduced 2 new Exact Diagnostic products including synthetic negative & HAI negative run control.

Latex Agglutination Test Kits Market Report Scope

Report Attributes


Market size value in 2024

USD 668.50 million

Revenue forecast in 2032

USD 1029.83 million


5.5% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD million and CAGR from 2023 to 2032

Segments covered

By Test Type, By Sample Type, By End User, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements with respect to countries, region and segmentation.


Latex Agglutination Test Kits Market Size Worth $ 1,029.83 Million By 2032

The top market players in Latex Agglutination Test Kits Market include Bio-Rad Laboratories, Eurofins Technologies, Mast Group, Pro Lab Diagnostics.

North America is contribute notably towards the Latex Agglutination Test Kits Market.

The global latex agglutination test kits market is expected to grow at a CAGR of 5.5% during the forecast period.

Latex Agglutination Test Kits Market report covering key segments are test type, sample type, end user, and region.